Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 1s (C1s) is a serine protease and a key enzyme in the classical pathway of the complement system. It forms part of the C1 complex, together with C1q and two molecules of C1r. Activated C1s cleaves complement components C4 and C2, which are critical for downstream events in the complement cascade including opsonization and cell lysis. Deficiency or dysfunction can result in immunodeficiency syndromes or contribute to autoimmune diseases.
Serine protease; cleaves C4 and C2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component 1s subcomponent (None).